Dr. Emily Rostholder, M.D.
What this data tells you about Dr. Rostholder
Dr. Emily Rostholder is a gastroenterology specialist in Jacksonville, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Rostholder performed 6,812 Medicare services across 1,272 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rostholder received a total of $4,288 from 34 pharmaceutical and/or device companies across 256 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rostholder is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 116290 | Clear | January 31, 2027 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Vedolizumab infusion (Entyvio) | 4,500 | $17 | $34 |
| Infliximab infusion (Remicade) | 910 | $26 | $125 |
| Office visit, established patient (30-39 min) | 255 | $92 | $275 |
| Colonoscopy with biopsy | 204 | $83 | $850 |
| Upper GI endoscopy with biopsy | 187 | $73 | $650 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 158 | $216 | $1,214 |
| Office visit, established patient (20-29 min) | 115 | $63 | $200 |
| Initial hospital admission, high complexity | 95 | $140 | $400 |
| Hospital follow-up visit, moderate complexity | 84 | $64 | $200 |
| Infusion, normal saline solution, 250 cc | 58 | $1 | $122 |
| New patient office visit (45-59 min) | 49 | $119 | $400 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 36 | $58 | $185 |
| Administration of chemotherapy into vein, 1 hour or less | 33 | $101 | $425 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 24 | $183 | $788 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $95 | $650 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 22 | $97 | $523 |
| Study of esophagus to assess movement | 17 | $51 | $270 |
| Administration of chemotherapy into vein, each additional hour | 16 | $22 | $102 |
| Initial hospital admission, moderate complexity | 14 | $106 | $300 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 12 | $4 | $25 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
5.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rostholder is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rostholder experienced with vedolizumab infusion (entyvio)?
Does Dr. Rostholder receive payments from pharmaceutical companies?
How do Dr. Rostholder's costs compare to other gastroenterologists in Jacksonville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology